(Q42959216)

11 November 2017

Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues (English)

1 reference

11 November 2017

0 references

1 reference

D Simon

1

1 reference

11 November 2017

27 October 2009

1 reference

11 November 2017

1 reference

11 November 2017

53

1 reference

11 November 2017

1

1 reference

11 November 2017

204-205

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-009-1572-8

11 November 2017

0 references

cites work

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

Adjusting for multiple testing--when and how?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

Does diabetes therapy influence the risk of cancer?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789934

10.1007/S00125-009-1572-8

16 August 2018

Identifiers

DOI

1 reference

11 November 2017

1 reference

11 November 2017

1 reference

PMCID

2789934